FI45176C - Menetelmä pregnaanisarjan 4,6-dikloori- 4,6-steroidien valmistamiseksi . - Google Patents
Menetelmä pregnaanisarjan 4,6-dikloori- 4,6-steroidien valmistamiseksi .Info
- Publication number
- FI45176C FI45176C FI681532A FI153268A FI45176C FI 45176 C FI45176 C FI 45176C FI 681532 A FI681532 A FI 681532A FI 153268 A FI153268 A FI 153268A FI 45176 C FI45176 C FI 45176C
- Authority
- FI
- Finland
- Prior art keywords
- steroids
- dichloro
- preparation
- pregnane series
- pregnane
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1967SC040852 DE1643027B2 (de) | 1967-06-09 | 1967-06-09 | 4,6-dichlor-delta hoch 4,6- steroide der pregnanreihe |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI45176B FI45176B (fi) | 1971-12-31 |
| FI45176C true FI45176C (fi) | 1972-04-10 |
Family
ID=7435899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI681532A FI45176C (fi) | 1967-06-09 | 1968-05-31 | Menetelmä pregnaanisarjan 4,6-dikloori- 4,6-steroidien valmistamiseksi . |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US3789087A (fi) |
| AT (1) | AT280499B (fi) |
| BE (1) | BE716258A (fi) |
| BR (1) | BR6899582D0 (fi) |
| CH (1) | CH560230A5 (fi) |
| CS (1) | CS163723B2 (fi) |
| DE (1) | DE1643027B2 (fi) |
| DK (2) | DK124610B (fi) |
| ES (1) | ES354795A1 (fi) |
| FI (1) | FI45176C (fi) |
| FR (2) | FR1588812A (fi) |
| GB (1) | GB1240339A (fi) |
| NL (1) | NL161768C (fi) |
| NO (1) | NO129522B (fi) |
| PL (1) | PL73566B1 (fi) |
| SE (1) | SE341396B (fi) |
| YU (1) | YU33977B (fi) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0792152B1 (en) | 1994-11-22 | 2004-04-14 | Balance Pharmaceuticals, Inc. | Methods of contraception |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB838773A (en) * | 1955-07-20 | 1960-06-22 | Farmaceutici Italia | 4-substituted steroid compounds and preparation thereof |
| US3452058A (en) * | 1958-11-13 | 1969-06-24 | Syntex Corp | 6-substituted-6-dehydro androstanes and pregnanes |
| GB1050218A (fi) * | 1964-10-13 | |||
| DE1593516C3 (de) * | 1966-08-25 | 1975-05-15 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | 4-Halogen-1,2 alpha; 6,7 betabismethylen-delta hoch 4-3-ketosteroide, Verfahren zu ihrer Herstellung sowie diese Steroide enthaltende Mittel |
| US3707537A (en) * | 1969-01-08 | 1972-12-26 | Hoffmann La Roche | 4-chloro-4,6-diene-6-halo or lower alkyl steroids |
-
1967
- 1967-06-09 DE DE1967SC040852 patent/DE1643027B2/de active Granted
-
1968
- 1968-05-21 DK DK234568AA patent/DK124610B/da unknown
- 1968-05-29 AT AT516368A patent/AT280499B/de not_active IP Right Cessation
- 1968-05-31 FI FI681532A patent/FI45176C/fi active
- 1968-06-03 YU YU1278/68A patent/YU33977B/xx unknown
- 1968-06-04 CH CH828768A patent/CH560230A5/xx not_active IP Right Cessation
- 1968-06-05 SE SE07534/68A patent/SE341396B/xx unknown
- 1968-06-05 BR BR199582/68A patent/BR6899582D0/pt unknown
- 1968-06-05 US US00734513A patent/US3789087A/en not_active Expired - Lifetime
- 1968-06-06 CS CS4207A patent/CS163723B2/cs unknown
- 1968-06-07 NO NO02226/68A patent/NO129522B/no unknown
- 1968-06-07 BE BE716258D patent/BE716258A/xx unknown
- 1968-06-07 FR FR1588812D patent/FR1588812A/fr not_active Expired
- 1968-06-07 ES ES354795A patent/ES354795A1/es not_active Expired
- 1968-06-08 NL NL6808107.A patent/NL161768C/xx not_active IP Right Cessation
- 1968-06-08 PL PL12743668A patent/PL73566B1/xx unknown
- 1968-06-10 GB GB27559/68A patent/GB1240339A/en not_active Expired
- 1968-09-05 FR FR165163A patent/FR8342M/fr not_active Expired
-
1971
- 1971-07-08 DK DK336171AA patent/DK128189B/da unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL161768B (nl) | 1979-10-15 |
| FR1588812A (fi) | 1970-03-16 |
| AT280499B (de) | 1970-04-10 |
| BR6899582D0 (pt) | 1973-05-10 |
| CH560230A5 (fi) | 1975-03-27 |
| YU127868A (en) | 1978-02-28 |
| DE1643027B2 (de) | 1977-12-08 |
| NL6808107A (fi) | 1968-12-10 |
| DE1643027C3 (fi) | 1978-08-17 |
| FR8342M (fi) | 1970-12-21 |
| BE716258A (fi) | 1968-12-09 |
| NL161768C (nl) | 1980-03-17 |
| DE1643027A1 (de) | 1971-04-15 |
| ES354795A1 (es) | 1969-11-01 |
| CS163723B2 (fi) | 1975-11-07 |
| YU33977B (en) | 1978-09-08 |
| NO129522B (fi) | 1974-04-22 |
| SE341396B (fi) | 1971-12-27 |
| US3789087A (en) | 1974-01-29 |
| DK124610B (da) | 1972-11-06 |
| DK128189B (da) | 1974-03-18 |
| PL73566B1 (fi) | 1974-10-31 |
| GB1240339A (en) | 1971-07-21 |
| FI45176B (fi) | 1971-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK121857B (da) | Analogifremgangsmåde til fremstilling af 11β-alkyloxy-13β-alkylgona-1,3,5,(10)-trienderivater. | |
| FI48727C (fi) | Menetelmä asetyyliguanidiinien valmistamiseksi. | |
| DK118877B (da) | Analogifremgangsmåde til fremstilling af 3,1-benzoxazin-2-oner. | |
| DK129234B (da) | Fremgangsmåde til fremstilling af levo-1-n-butyl-2',6'-pipecoloxylidid. | |
| DK118246B (da) | Analogifremgangsmåde til fremstilling af 2-isothiuroniummethyl-3-carboxylsyreamido-quinozalin-di-N-oxid-(1,4)-halogenider. | |
| DK115617B (da) | Fremgangsmåde til fremstilling af 2,2-dichlor-1,1,3,3-tetrafluorpropan. | |
| DK119166B (da) | Fremgangsmåde til fremstilling af 1,4-bezodiazepinderivater. | |
| DK116357B (da) | Fremgangsmåde til fremstilling af 1,1,1,2,2-pentafluor-3-chlorpropan. | |
| DK120347B (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepin-4-oxider. | |
| DK123169B (da) | Fremgangsmåde til fremstilling af 2,5-dichlor-4-alkylmercaptophenoler. | |
| DK119609B (da) | Analogifremgangsmåde til fremstilling af 2α,2β, 17α-trimethyl-13β-alkylgona-4,9,11-trien-17β-oler. | |
| FI45176C (fi) | Menetelmä pregnaanisarjan 4,6-dikloori- 4,6-steroidien valmistamiseksi . | |
| DK126936B (da) | Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener. | |
| DK124882B (da) | Analogifremgangsmåde til fremstilling af 17α-acyloxy-11β-methyl-19-norpregn-4-en-3,20-dioner. | |
| DK115622B (da) | Fremgangsmåde til fremstilling af 3-oxogona-4,9,11-triener. | |
| DK120131B (da) | Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener. | |
| DK122275B (da) | Fremgangsmåde til fremstilling af 17α-ætynyl-17β-hydroksysteroider af androstan- eller østranrækken. | |
| FI45324C (fi) | Menetelmä 17beta-(1-alkoksi-sykloalkyyli)oksi-2alfa,3alfa-epitio-5alfa -androstaanien valmistamiseksi. | |
| DK125083B (da) | Fremgangsmåde til fremstilling af 2,3-diklor-4-butyryl-fenoxyeddikesyre. | |
| DK137494B (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater. | |
| DK123476B (da) | Fremgangsmåde til fremstilling af 3-oxo-A-nor-B-homo-estra-5(10)-ener. | |
| DK129842B (da) | Fremgangsmåde til fremstilling af 3-imino-1,2-benzisothiazoliner. | |
| DK112319B (da) | Fremgangsmåde til fremstilling af 7-nitrosubstituerede 1,4-benzodiazepinoner. | |
| DK116208B (da) | Analogifremgangsmåde til fremstilling af 17-hydroxy- eller 17-acyloxy-6β, 7β-epoxy-1α, 2α-methylen-4-pregnen-3,20-dioner. | |
| DK122175B (da) | Analogifremgangsmåde til fremstilling af 3-oxo-13β-alkyl-17α-allyl-17β-hydroxygona-4,9,11-triener. |